Skip to main content
Top
Published in: BMC Infectious Diseases 1/2006

Open Access 01-12-2006 | Research article

Measles transmission following the tsunami in a population with a high one-dose vaccination coverage, Tamil Nadu, India 2004–2005

Authors: Arumugam Mohan, Manoj V Murhekar, Niteen S Wairgkar, Yvan J Hutin, Mohan D Gupte

Published in: BMC Infectious Diseases | Issue 1/2006

Login to get access

Abstract

Background

On 26 December 2004, a tsunami struck the coast of the state of Tamil Nadu, India, where one-dose measles coverage exceeded 95%. On 29 December, supplemental measles immunization activities targeted children 6 to 60 months of age in affected villages. On 30 December, Cuddalore, a tsunami-affected district in Tamil Nadu reported a cluster of measles cases. We investigated this cluster to estimate the magnitude of the problem and to propose recommendations for control.

Methods

We received notification of WHO-defined measles cases through stimulated passive surveillance. We collected information regarding date of onset, age, sex, vaccination status and residence. We collected samples for IgM antibodies and genotype studies. We modeled the accumulation of susceptible individuals over the time on the basis of vaccination coverage, vaccine efficacy and birth rate.

Results

We identified 101 measles cases and detected IgM antibodies against measles virus in eight of 11 sera. Cases were reported from tsunami-affected (n = 71) and unaffected villages (n = 30) with attack rates of 1.3 and 1.7 per 1000, respectively. 42% of cases in tsunami-affected villages had an onset date within 14 days of the tsunami. The median ages of case-patients in tsunami-affected and un-affected areas were 54 months and 60 months respectively (p = 0.471). 36% of cases from tsunami-affected areas were above 60 months of age. Phylogenetic analyses indicated that the sequences of virus belonged to genotype D8 that circulated in Tamil Nadu.

Conclusion

Measles virus circulated in Cuddalore district following the tsunami, although there was no association between the two events. Transmission despite high one-dose vaccination coverage pointed to the limitations of this vaccination strategy. A second opportunity for measles immunization may help reducing measles mortality and morbidity in such areas. Children from 6 month to 14 years of age must be targeted for supplemental immunization during complex emergencies.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO UNICEF: Joint Statement on Strategies to reduce measles mortality worldwide. 2001, WHO/V&B/0.1/40 WHO UNICEF: Joint Statement on Strategies to reduce measles mortality worldwide. 2001, WHO/V&B/0.1/40
2.
go back to reference WHO UNICEF: Measles mortality reduction and regional elimination. Strategic plan 2001–2005. WHO/V&B/01, 13 March 2003 WHO UNICEF: Measles mortality reduction and regional elimination. Strategic plan 2001–2005. WHO/V&B/01, 13 March 2003
3.
go back to reference Centers for Disease control and Prevention (CDC): Progress in reducing measles mortality-worldwide, 1999–2003. MMWR Morb Mortal Wkly Rep. 2005, 54: 2003- Centers for Disease control and Prevention (CDC): Progress in reducing measles mortality-worldwide, 1999–2003. MMWR Morb Mortal Wkly Rep. 2005, 54: 2003-
4.
go back to reference Puvimanasinghe JP, Arambepola CK, Abeysinghe NM, Rajapaksa LC, Kulatilaka TA: Measles outbreak in Sri Lanka, 1999–2000. J Infect Dis. 2003, 187 (Suppl 1): S241-5. 10.1086/368047.CrossRefPubMed Puvimanasinghe JP, Arambepola CK, Abeysinghe NM, Rajapaksa LC, Kulatilaka TA: Measles outbreak in Sri Lanka, 1999–2000. J Infect Dis. 2003, 187 (Suppl 1): S241-5. 10.1086/368047.CrossRefPubMed
5.
go back to reference De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G: Progress toward measles eradication in the region of the Americas. J Infect Dis. 2003, 187 (Suppl 1): S102-10. 10.1086/368032.CrossRefPubMed De Quadros CA, Izurieta H, Carrasco P, Brana M, Tambini G: Progress toward measles eradication in the region of the Americas. J Infect Dis. 2003, 187 (Suppl 1): S102-10. 10.1086/368032.CrossRefPubMed
6.
go back to reference Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P: Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. J Infect Dis. 2003, 187 (Suppl 1): S217-22. 10.1086/368228.CrossRefPubMed Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P: Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. J Infect Dis. 2003, 187 (Suppl 1): S217-22. 10.1086/368228.CrossRefPubMed
7.
go back to reference McFarland JW, Mansoor OD, Yang B: Accelerated measles control in the western pacific region. J infect Dis. 2003, 187 (Suppl): S246-S51. 10.1086/368039.CrossRefPubMed McFarland JW, Mansoor OD, Yang B: Accelerated measles control in the western pacific region. J infect Dis. 2003, 187 (Suppl): S246-S51. 10.1086/368039.CrossRefPubMed
8.
go back to reference Kamugisha C, Cairns KL, Akim C: An Outbreak of Measles in Tanzanian Refugee Camps. J Inf Dis. 2003, 187 (Suppl): S58-S62. 10.1086/368057.CrossRef Kamugisha C, Cairns KL, Akim C: An Outbreak of Measles in Tanzanian Refugee Camps. J Inf Dis. 2003, 187 (Suppl): S58-S62. 10.1086/368057.CrossRef
9.
go back to reference Porter JD, Gastellu-Etchegorry M, Navarre I, Lungu G, Moren A: Measles outbreaks in the Mozambican refugee camps in Malawi: the continued need for an effective vaccine. Int J Epidemiol. 1990, 19: 1072-1077.CrossRefPubMed Porter JD, Gastellu-Etchegorry M, Navarre I, Lungu G, Moren A: Measles outbreaks in the Mozambican refugee camps in Malawi: the continued need for an effective vaccine. Int J Epidemiol. 1990, 19: 1072-1077.CrossRefPubMed
11.
go back to reference Toole MJ, Steketee RW, Waldman RJ, Nieburg P: Measles prevention and control in emergency settings. Bull World Health Organ. 1989, 67: 381-8.PubMedPubMedCentral Toole MJ, Steketee RW, Waldman RJ, Nieburg P: Measles prevention and control in emergency settings. Bull World Health Organ. 1989, 67: 381-8.PubMedPubMedCentral
12.
go back to reference Toole MJ, Waldman RJ: An analysis of mortality trends among refugee populations in Somalia, Sudan, and Thailand. Bull World Health Organ. 1988, 66: 237-47.PubMedPubMedCentral Toole MJ, Waldman RJ: An analysis of mortality trends among refugee populations in Somalia, Sudan, and Thailand. Bull World Health Organ. 1988, 66: 237-47.PubMedPubMedCentral
13.
go back to reference Medecins Sans Frontieres. Refugee health. An approach to emergency situations. MacMillan education Ltd. Edited by: Habquet G. 1997 Medecins Sans Frontieres. Refugee health. An approach to emergency situations. MacMillan education Ltd. Edited by: Habquet G. 1997
14.
go back to reference WHO UNICEF Joint statement: Reducing measles mortality in complex emergencies. 2004, WHO/V &B/04.03 WHO UNICEF Joint statement: Reducing measles mortality in complex emergencies. 2004, WHO/V &B/04.03
16.
go back to reference WHO: WHO Guidelines for Epidemic Preparedness and Response to Measles outbreaks. 1999, WHO/CDS/CSR/ISR/99.1, 11- WHO: WHO Guidelines for Epidemic Preparedness and Response to Measles outbreaks. 1999, WHO/CDS/CSR/ISR/99.1, 11-
17.
go back to reference Murhekar MV, Manickam P, Ramachandran V, Ramakrishnan R, Sen TK, Solanki SS, Martolia HCS, Jain PK, Tamta TK, Ezil R, Sundarmoorthy L, Selvaraj V, Joshua V, Murthy BN, Nagaraju B, Hutin Y, Gupte MD: Surveillance of outbreak prone diseases in tsunami affeted areas. ICMR Response to tsunami. Edited by: Gupte MD. 2005, 7-10. Murhekar MV, Manickam P, Ramachandran V, Ramakrishnan R, Sen TK, Solanki SS, Martolia HCS, Jain PK, Tamta TK, Ezil R, Sundarmoorthy L, Selvaraj V, Joshua V, Murthy BN, Nagaraju B, Hutin Y, Gupte MD: Surveillance of outbreak prone diseases in tsunami affeted areas. ICMR Response to tsunami. Edited by: Gupte MD. 2005, 7-10.
19.
go back to reference WHO: Measles vaccines. WHO Position paper. Weekly epidemiological record No. 14. 2004, 130-141. WHO: Measles vaccines. WHO Position paper. Weekly epidemiological record No. 14. 2004, 130-141.
20.
go back to reference de Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, Alleyne GA: Measles elimination in the Americas. Evolving strategies. JAMA. 1996, 275: 224-9. 10.1001/jama.275.3.224.CrossRefPubMed de Quadros CA, Olive JM, Hersh BS, Strassburg MA, Henderson DA, Brandling-Bennett D, Alleyne GA: Measles elimination in the Americas. Evolving strategies. JAMA. 1996, 275: 224-9. 10.1001/jama.275.3.224.CrossRefPubMed
21.
go back to reference Rota PA, Liffick SL, Rota JS, Katz RS, Redd S, Papania M, Bellini WJ: Molecular epidemiology of measles viruses in the United States, 1997–2001. Emerg Infect Dis. 2002, 8: 902-8.CrossRefPubMedPubMedCentral Rota PA, Liffick SL, Rota JS, Katz RS, Redd S, Papania M, Bellini WJ: Molecular epidemiology of measles viruses in the United States, 1997–2001. Emerg Infect Dis. 2002, 8: 902-8.CrossRefPubMedPubMedCentral
22.
go back to reference Toole MJ: Mass population displacement. A global public health challenge. Infect Dis Clin North Am. 1995, 9: 353-66.PubMed Toole MJ: Mass population displacement. A global public health challenge. Infect Dis Clin North Am. 1995, 9: 353-66.PubMed
23.
go back to reference Sivasankaran S, Manickam P, Ramakrishnan R, Hutin Y, Gupte MD, Centers for Disease Control and Prevention (CDC): Estimation of measles vaccination coverage by using the lot quality assurance sampling (LQAS) method-Tamil Nadu, India, 2002–2003. MMWR Morb Mortal Wkly Rep. 2006, 55 (Suppl 1): 16-9. Sivasankaran S, Manickam P, Ramakrishnan R, Hutin Y, Gupte MD, Centers for Disease Control and Prevention (CDC): Estimation of measles vaccination coverage by using the lot quality assurance sampling (LQAS) method-Tamil Nadu, India, 2002–2003. MMWR Morb Mortal Wkly Rep. 2006, 55 (Suppl 1): 16-9.
24.
go back to reference Strebel P, Cochi S, Grabowsky M, Bilous J, Hersh BS, Okwo-Bele JM, Hoekstra E, Wright P, Katz S: The unfinished measles immunization agenda. J Infect Dis. 2003, 187 (Suppl 1): S1-7. 10.1086/368226.CrossRefPubMed Strebel P, Cochi S, Grabowsky M, Bilous J, Hersh BS, Okwo-Bele JM, Hoekstra E, Wright P, Katz S: The unfinished measles immunization agenda. J Infect Dis. 2003, 187 (Suppl 1): S1-7. 10.1086/368226.CrossRefPubMed
26.
go back to reference Shefer A, Briss P, Rodewald L, Bernier R, Strikas R, Yusuf H: Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev. 1999, 21: 96-142.CrossRefPubMed Shefer A, Briss P, Rodewald L, Bernier R, Strikas R, Yusuf H: Improving immunization coverage rates: an evidence-based review of the literature. Epidemiol Rev. 1999, 21: 96-142.CrossRefPubMed
Metadata
Title
Measles transmission following the tsunami in a population with a high one-dose vaccination coverage, Tamil Nadu, India 2004–2005
Authors
Arumugam Mohan
Manoj V Murhekar
Niteen S Wairgkar
Yvan J Hutin
Mohan D Gupte
Publication date
01-12-2006
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2006
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-6-143

Other articles of this Issue 1/2006

BMC Infectious Diseases 1/2006 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.